Okyo Pharma Ltd: Clinical Trials

3 trials sponsored by Okyo Pharma Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 terminated. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 31Not yet recruiting 1

Follow Okyo Pharma Ltd: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Study Assessing the Safety and Efficacy of Urcosimod Ophthalmic Solution in Participants With Neuropathic Corneal Pain (NCP).
Urcosimod ophthalmic solution is a preservative-free topical ophthalmic product; supplied in unit dose ampoules; administered QID for 12-weeks., Vehicle Ophthalmic Solution - Neuropathic Corneal Pain
Phase 3Not yet recruitingOkyo Pharma Ltd1112026-09-012026-09-29
The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal Pain
OK-101 0.05%, OK-101 0.1%, Placebo - Neuropathic Pain
Phase 2TerminatedOkyo Pharma Ltd182024-10-152025-08-15
The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease
OK-101, Placebo - Dry Eye Disease
Phase 2CompletedOkyo Pharma Ltd2402023-04-282024-02-09

Conditions studied

Dry Eye Syndromes (1)  ·  Eye Pain (1)  ·  Neuralgia (1)

Interventions

Equipment and Supplies (1)

Countries

United States (3)

Top investigators

Flavio Mantelli, MD, PhD (1)  ·  Pedram Hamrah, MD (1)  ·  Raj Patil, PhD (1)